Weining Lu

Boston Medical Center

$3,572,944

Attributed

$3,811,949

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $478K · FY2008–25

$500K$375K$250K$125K$0

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,811,949 · 3

By mechanism

R01$3,333,938 · 2

R21$478,011 · 1

Top collaborators

Chao Zhang1 shared

Others in their field

Top investigators on “Novel Therapeutics”

David Heimbrook · Leidos Biomedical Research, Inc.$355,066,875
Judith S. Currier · University Of California Los Angeles$321,442,024
Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
Daniel R Kuritzkes · Brigham And Women'S Hospital$246,024,897
Sharon A Nachman · Johns Hopkins University$212,395,175

Research focus

Novel TherapeuticsMorbidity - Disease RateKidney DiseasesProteinuriaKidneyUrinary TractRefluxUrinePlayMetanephric DiverticulumBirthSignal TransductionMutationKidney FailureVesico-Ureteral RefluxStructurePodocyteNephrogenesisFocal Segmental GlomerulosclerosisAdultPositioning AttributeLeadInjuryLigands